CAMBRIDGE CANCER GENOMICS LTD.
CAMBRIDGE

Hellopages » Cambridgeshire » Cambridge » CB2 1NN

Company number 10583580
Status Active
Incorporation Date 25 January 2017
Company Type Private Limited Company
Address EMIL HEWAGE, 8 BATEMAN MEWS, BATEMAN MEWS, CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM, CB2 1NN
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration one events have happened. The last one records are Incorporation Statement of capital on 2017-01-25 GBP 150 MODEL ARTICLES ‐ Model articles adopted . The most likely internet sites of CAMBRIDGE CANCER GENOMICS LTD. are www.cambridgecancergenomics.co.uk, and www.cambridge-cancer-genomics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eight years and ten months. Cambridge Cancer Genomics Ltd is a Private Limited Company. The company registration number is 10583580. Cambridge Cancer Genomics Ltd has been working since 25 January 2017. The present status of the company is Active. The registered address of Cambridge Cancer Genomics Ltd is Emil Hewage 8 Bateman Mews Bateman Mews Cambridge Cambridgeshire United Kingdom Cb2 1nn. . CASSIDY, John William is a Director of the company. CLIFFORD, Harry, Dr is a Director of the company. PATEL, Nirmesh is a Director of the company. TSAI, Evaline is a Director of the company. CAMBRIDGE APPLIED RESEARCH is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
CASSIDY, John William
Appointed Date: 25 January 2017
37 years old

Director
CLIFFORD, Harry, Dr
Appointed Date: 25 January 2017
35 years old

Director
PATEL, Nirmesh
Appointed Date: 25 January 2017
35 years old

Director
TSAI, Evaline
Appointed Date: 25 January 2017
32 years old

Director
CAMBRIDGE APPLIED RESEARCH
Appointed Date: 25 January 2017

Persons With Significant Control

Mr John William Cassidy
Notified on: 25 January 2017
37 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

CAMBRIDGE CANCER GENOMICS LTD. Events

25 Jan 2017
Incorporation
Statement of capital on 2017-01-25
  • GBP 150
  • MODEL ARTICLES ‐ Model articles adopted